Critical Contrast: Consort Medical (CSRMY) & The Competition

Consort Medical (OTCMKTS: CSRMY) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its peers? We will compare Consort Medical to related businesses based on the strength of its valuation, institutional ownership, dividends, earnings, analyst recommendations, risk and profitability.

Analyst Ratings

This is a summary of current ratings for Consort Medical and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Consort Medical 0 0 0 0 N/A
Consort Medical Competitors 130 728 1292 61 2.58

As a group, “Surgical appliances & supplies” companies have a potential downside of 0.01%. Given Consort Medical’s peers higher possible upside, analysts clearly believe Consort Medical has less favorable growth aspects than its peers.

Volatility and Risk

Consort Medical has a beta of 0.1, suggesting that its stock price is 90% less volatile than the S&P 500. Comparatively, Consort Medical’s peers have a beta of 0.84, suggesting that their average stock price is 16% less volatile than the S&P 500.


This table compares Consort Medical and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Consort Medical N/A N/A N/A
Consort Medical Competitors -294.21% -54.23% -18.46%

Earnings and Valuation

This table compares Consort Medical and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Consort Medical $380.46 million $29.23 million 18.84
Consort Medical Competitors $1.34 billion $196.09 million 24.87

Consort Medical’s peers have higher revenue and earnings than Consort Medical. Consort Medical is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

54.6% of shares of all “Surgical appliances & supplies” companies are owned by institutional investors. 10.8% of shares of all “Surgical appliances & supplies” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Consort Medical pays an annual dividend of $0.24 per share and has a dividend yield of 1.5%. Consort Medical pays out 28.9% of its earnings in the form of a dividend. As a group, “Surgical appliances & supplies” companies pay a dividend yield of 1.2% and pay out 27.1% of their earnings in the form of a dividend.


Consort Medical peers beat Consort Medical on 8 of the 12 factors compared.

About Consort Medical

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak’s core business is the manufacture of inhaled drug delivery devices for life sciences partners and its operations are based in the United Kingdom. The Aesica business manufactures and sells active pharmaceutical ingredients (API), formulated pharmaceutical products and packaging services to the pharmaceutical industry and its operations are based in the United Kingdom and Europe. It offers its services to customers, such as pharmaceutical companies and life sciences. Its device products include metered dose inhalers, dry powder devices, actuators, dose counters, disposable auto-injectors, nasal devices and point-of-care diagnostics devices.

Receive News & Ratings for Consort Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical and related companies with's FREE daily email newsletter.

Leave a Reply